'Indian firms most responsible in CSR'

Countries look at India as a leader to emulate, says philathropist RUTH A SHAPIRO in an interview to Down To Earth. Edited excerpts:

Where are the doctors’ bodies when common man suffers due to poor treatment?

Notwithstanding lack of government support, the medical associations are strangely absent whenever the needy suffers due to unethical practices, …

Patients pay for high margins of pharma firms

Patients in India end up paying more for medicines and all kinds of treatment as prevailing conditions do not allow the market to function …

Online drug sale ban: Is there a need to regulate e-pharmacies?

Following an interim ban on online sale of medicines, many questions have been raised on the need for checks and balances

Trial by hire

Laissez-faire in clinical research has unleashed a ruthless profit-making machine blind to notions of justice or equity. It is time to rein in …

Supreme abuse

Bulk drug makers at Patancheru continue to pollute in the absence of effective vigilance, shows an analysis by the Centre for Science and Environment

Single nanoparticle twists pave the way for medicines on demand: Study

Understanding chirality — twists within nanoparticles — can help several industries, including pharma 

Drug trials: SC pulls up Centre for not compensating victims who suffered severe adverse effects

Asks government to pay victims and recover the money from pharma companies sponsoring the drug trials later

Average 71 patents per drug!

Innovator companies are seeking hundreds of patents on a single drug to extend monopolies and increase prices

Coffins for the EU Delegation in Delhi

Health activists protest against the EU-India investment treaty under negotiation now